Best of 2023: Time to Risk Stratify Methotrexate Lab Monitoring?
A longitudinal cohort analysis has developed a prognostic model that informs a risk stratified approach to monitoring blood tests during long term methotrexate (MTX) therapy.
https://t.co/WZcJugj3Bg https://t.co/HQ3Xg9h0md
Links:
Best of 2023: Time to Risk Stratify Methotrexate Lab Monitoring? | RheumNow
https://bit.ly/477vFoL
Dec-21-2023


